$0.26
-0.0086[-3.22%]
Last update: 8:41AM Get Real Time Here
MariMed Stock (OTC:MRMD), Analyst Ratings, Price Targets, Predictions
MariMed Inc has a consensus price target of $0.42, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Zuanic & Associates and BTIG on November 6, 2023 and October 28, 2022. With an average price target of $0.42 between Zuanic & Associates and BTIG, there's an implied 57.41% upside for MariMed Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Zuanic & Associates
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for MariMed
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/06/2023 | MRMD | Buy Now | MariMed | $0.27 | — | Zuanic & Associates | Pablo Zuanic | — | Initiates | → Overweight | Get Alert |
| 10/28/2022 | MRMD | Buy Now | MariMed | $0.27 | 214.81% | BTIG | Jonathan Decourcey | → $0.85 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for MariMed (MRMD)?
The latest price target for MariMed (OTCQX: MRMD) was reported by Zuanic & Associates on November 6, 2023. The analyst firm set a price target for $0.00 expecting MRMD to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MariMed (MRMD)?
The latest analyst rating for MariMed (OTCQX: MRMD) was provided by Zuanic & Associates, and MariMed initiated their overweight rating.
When was the last upgrade for MariMed (MRMD)?
There is no last upgrade for MariMed.
When was the last downgrade for MariMed (MRMD)?
There is no last downgrade for MariMed.
When is the next analyst rating going to be posted or updated for MariMed (MRMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MariMed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MariMed was filed on November 6, 2023 so you should expect the next rating to be made available sometime around November 6, 2024.
Is the Analyst Rating MariMed (MRMD) correct?
While ratings are subjective and will change, the latest MariMed (MRMD) rating was a initiated with a price target of $0.00 to $0.00. The current price MariMed (MRMD) is trading at is $0.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.